Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Dyno Therapeutics

Dyno Therapeutics develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. Our data-driven approach combines next-generation DNA synthesis of millions of AAV capsids with high-throughput sequencing and machine learning.

 

  • Eric Kelsic, PhD Co-founder and CEO
  • Alan Crane Co-founder and Executive Chairman
  • Adrian Veres, PhD Co-founder, Advisor
  • Sam Sinai, PhD Co-founder and Lead ML Scientist
  • George Church, PhD Co-founder